Biotech · Public company · Washington, DC, US

Vanda Pharmaceuticals Inc.

Ticker VNDA · SEC CIK 0001347178

Track this companyFree. Adds Vanda Pharmaceuticals Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials2517 recruiting or active

Pipeline programs27From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline27

300 mg ImsidolimabPhase 3 · Generalized Pustular PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
750 mg ImsidolimabPhase 3 · Generalized Pustular PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
Double-blind 200 mg imsidolimabPhase 3 · Generalized Pustular PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
iloperidonePhase 3 · SchizophreniaClinicalTrials.gov · fetched Nov 12, 2026
Imsidolimab 750 mg IV/200 mg SCPhase 3 · Generalized Pustular PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
MilsaperidonePhase 3 · Major Depressive Disorder (MDD)ClinicalTrials.gov · fetched Nov 12, 2026
Open Label TradipitantPhase 3 · Idiopathic GastroparesisClinicalTrials.gov · fetched Nov 12, 2026
Open-label 200 mg imsidolimabPhase 3 · Generalized Pustular PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
PonesimodPhase 3 · Ulcerative Colitis (UC)ClinicalTrials.gov · fetched Nov 12, 2026
PonesimodPhase 3 · Moderate-to-severe Chronic Plaque PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
TasimelteonPhase 3 · Sleep Wake DisordersClinicalTrials.gov · fetched Nov 12, 2026
Tasimelteon Oral SuspensionPhase 3 · Insomnia DisorderClinicalTrials.gov · fetched Nov 12, 2026
TradipitantPhase 3 · Idiopathic GastroparesisClinicalTrials.gov · fetched Nov 12, 2026
TradipitantPhase 3 · Nausea and VomitingClinicalTrials.gov · fetched Nov 12, 2026
TradipitantPhase 3 · Coronavirus InfectionClinicalTrials.gov · fetched Nov 12, 2026
TradipitantPhase 3 · Motion SicknessClinicalTrials.gov · fetched Nov 12, 2026
VQW-765Phase 3 · Social Anxiety Disorder (SAD)ClinicalTrials.gov · fetched Nov 12, 2026
ZiprasidonePhase 3 · SchizophreniaClinicalTrials.gov · fetched Nov 12, 2026
iloperidonePhase 2 · HypertensionClinicalTrials.gov · fetched Nov 12, 2026
ImsidolimabPhase 2 · Acneiform EruptionsClinicalTrials.gov · fetched Nov 12, 2026
TradipitantPhase 2 · ObesityClinicalTrials.gov · fetched Nov 12, 2026
Trichostatin APhase 2 · Onychomycosis of ToenailClinicalTrials.gov · fetched Nov 12, 2026
VCA-894APhase 2 · Charcot Marie Tooth Disease (CMT)ClinicalTrials.gov · fetched Nov 12, 2026
VSJ-110Phase 2 · Dry EyeClinicalTrials.gov · fetched Nov 12, 2026
Trichostatin APhase 1 · Relapsed or Refractory Hematologic MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
Data collection of sleep disturbances in individuals with SMSSleep Disturbances in Smith-Magenis SyndromeClinicalTrials.gov · fetched Nov 12, 2026
Data collection on blindness and sleep problemsSleep-wake Disorder in Blind IndividualsClinicalTrials.gov · fetched Nov 12, 2026

Clinical trials25

Study to Evaluate the Efficacy and Safety of Ponesimod (VSP-128) in Patients With Moderately to Severely Active Ulcerative ColitisPHASE3 · RECRUITING · started Sep 1, 2026ClinicalTrials.gov NCT07686081 · fetched Nov 12, 2026
A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist UsePHASE3 · RECRUITING · started Mar 27, 2026ClinicalTrials.gov NCT07446439 · fetched Nov 12, 2026
Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque PsoriasisPHASE3 · RECRUITING · started Feb 17, 2026ClinicalTrials.gov NCT07362017 · fetched Nov 12, 2026
An Eight-Week Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry EyePHASE2 · RECRUITING · started Oct 1, 2025ClinicalTrials.gov NCT07179055 · fetched Nov 12, 2026
Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Social Anxiety DisorderPHASE3 · ACTIVE_NOT_RECRUITING · started Sep 22, 2025ClinicalTrials.gov NCT07221578 · fetched Nov 12, 2026
Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled HypertensionPHASE2 · RECRUITING · started Sep 15, 2025ClinicalTrials.gov NCT07090161 · fetched Nov 12, 2026
Randomized Withdrawal Study in Patients With SchizophreniaPHASE3 · RECRUITING · started May 14, 2025ClinicalTrials.gov NCT06961968 · fetched Nov 12, 2026
Treatment of Charcot-Marie-Tooth Disease, Axonal, Type 2S (CMT2S) in an Individual PatientPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started May 13, 2025ClinicalTrials.gov NCT07223632 · fetched Nov 12, 2026
Safety, Tolerability and Efficacy of Trichostatin A in Patients With Mild to Severe OnychomycosisPHASE2 · ACTIVE_NOT_RECRUITING · started May 5, 2025ClinicalTrials.gov NCT07065773 · fetched Nov 12, 2026
Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric InsomniaPHASE3 · RECRUITING · started Apr 21, 2025ClinicalTrials.gov NCT06953869 · fetched Nov 12, 2026
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive DisorderPHASE3 · RECRUITING · started Mar 3, 2025ClinicalTrials.gov NCT06830044 · fetched Nov 12, 2026
A Study to Measure the Effects of Using Tradipitant on Nausea and Vomiting After GLP-1R Agonist UsePHASE2 · COMPLETED · started Feb 25, 2025ClinicalTrials.gov NCT06804603 · fetched Nov 12, 2026
The Effects of Tasimelteon in Participants With REM Behavior Disorder (RBD)EARLY_PHASE1 · TERMINATED · started Sep 30, 2023ClinicalTrials.gov NCT05922995 · fetched Nov 12, 2026
Safety and Tolerability of Open-Labeled Iloperidone in AdolescentsPHASE4 · RECRUITING · started May 24, 2023ClinicalTrials.gov NCT05648591 · fetched Nov 12, 2026
Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion SicknessPHASE3 · ACTIVE_NOT_RECRUITING · started Feb 27, 2023ClinicalTrials.gov NCT06138613 · fetched Nov 12, 2026
Study to Evaluate the Long-Term Safety and Efficacy of Imsidolimab (ANB019) in the Treatment of Subjects With GPPPHASE3 · TERMINATED · started Apr 21, 2022ClinicalTrials.gov NCT05366855 · fetched Nov 12, 2026
Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Subjects With GPPPHASE3 · COMPLETED · started Apr 14, 2022ClinicalTrials.gov NCT05352893 · fetched Nov 12, 2026
A Study to Evaluate of the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Acneiform RashPHASE2 · TERMINATED · started May 4, 2021ClinicalTrials.gov NCT04697069 · fetched Nov 12, 2026
Evaluating the Effects of Tasimelteon vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD)PHASE3 · COMPLETED · started Dec 9, 2020ClinicalTrials.gov NCT04652882 · fetched Nov 12, 2026
ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 InfectionPHASE3 · ENROLLING_BY_INVITATION · started Apr 13, 2020ClinicalTrials.gov NCT04326426 · fetched Nov 12, 2026
Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic GastroparesisPHASE3 · COMPLETED · started Aug 20, 2019ClinicalTrials.gov NCT04028492 · fetched Nov 12, 2026
Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic MalignanciesPHASE1 · RECRUITING · started Sep 27, 2018ClinicalTrials.gov NCT03838926 · fetched Nov 12, 2026
Development of Clinical Database of Individuals With Smith-Magenis Syndrome and Sleep DisturbancesRECRUITING · started Jan 1, 2016ClinicalTrials.gov NCT03154697 · fetched Nov 12, 2026
Patient Registry of Blind Subjects With Sleep-related ProblemsRECRUITING · started Apr 1, 2010ClinicalTrials.gov NCT01195558 · fetched Nov 12, 2026
Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute SchizophreniaPHASE3 · COMPLETED · started Nov 18, 2005ClinicalTrials.gov NCT00254202 · fetched Nov 12, 2026

SEC filings12

10-Q · 10-QSEC EDGAR · filed Oct 29, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Oct 28, 2026 · fetched Nov 12, 2026
10-Q · 10-QSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Aug 5, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Jun 5, 2026 · fetched Nov 12, 2026
10-Q · 10-QSEC EDGAR · filed May 7, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed May 6, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Apr 22, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Apr 2, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Mar 10, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Feb 23, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Feb 19, 2026 · fetched Nov 12, 2026